Bethesda (1)

Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma (1)

Diffuse, Large B-cell Lymphoma (1)

Mantle Cell (1)

Primary Mediastinal B-cell Lymphoma (1)

Completed (1)

phase 1/phase 2 (1)

National Cancer Institute (NCI) (1)

aldesleukin (1)

anti-cluster of differentiation 19 (cd19)-car pbl (1)

cyclophosphamide (1)

fludarabine (1)

biological (1)

drug (1)

NIH (1)

Interventional (1)

mantle cell

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Completed

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Dec 29, 2021